Oncternal Therapeutics Inc (ONCT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-04-10 | 2024-04-08 | B Purchase | Non-Executive Director |
3,086
+44.6%
8.96USD 27,655 |
3,086 +44.6% | 8.96 | USD 27,655 | |
| 2024-04-01 | 2024-03-28 | B Purchase | Non-Executive Director |
6,914
+inf%
8.48USD 58,602 |
6,914 +inf% | 8.48 | USD 58,602 | |
| 2024-02-27 | 2024-02-23 | S Sale | Non-Executive Director |
980
-100.0%
9.04USD 8,859 |
980 -100.0% | 9.04 | USD 8,859 | |
| 2024-02-27 | 2024-02-23 | B Purchase | Non-Executive Director |
266
+0.9%
9.04USD 2,405 |
266 +0.9% | 9.04 | USD 2,405 | |
| 2024-02-27 | 2024-02-23 | B Purchase | Non-Executive Director |
714
+inf%
9.04USD 6,455 |
714 +inf% | 9.04 | USD 6,455 | |
| 2023-06-14 | 2023-06-14 | B Purchase |
Chief Scientific Officer Officer |
3,000
+3.3%
0.36USD 1,079 |
3,000 +3.3% | 0.36 | USD 1,079 | |
| 2023-06-14 | 2023-06-12 | B Purchase |
Chief Scientific Officer Officer |
25,000
+37.5%
0.35USD 8,745 |
25,000 +37.5% | 0.35 | USD 8,745 | |
| 2023-04-17 | 2023-04-14 | B Purchase |
Chief Executive Officer Executive Director |
2,250
+1.2%
0.29USD 653 |
2,250 +1.2% | 0.29 | USD 653 | |
| 2023-04-17 | 2023-04-14 | B Purchase |
Chief Executive Officer Executive Director |
47,750
+32.6%
0.30USD 14,277 |
47,750 +32.6% | 0.30 | USD 14,277 | |
| 2023-04-14 | 2023-04-14 | B Purchase |
Chief Medical Officer Officer |
5,000
+3.1%
0.30USD 1,500 |
5,000 +3.1% | 0.30 | USD 1,500 | |
| 2023-04-17 | 2023-04-13 | B Purchase |
Chief Executive Officer Executive Director |
100,000
+214.9%
0.29USD 29,000 |
100,000 +214.9% | 0.29 | USD 29,000 | |
| 2023-04-14 | 2023-04-13 | B Purchase |
Chief Financial Officer Officer |
30,000
+23.6%
0.30USD 8,961 |
30,000 +23.6% | 0.30 | USD 8,961 | |
| 2023-04-14 | 2023-04-13 | B Purchase |
Chief Medical Officer Officer |
10,000
+6.7%
0.29USD 2,850 |
10,000 +6.7% | 0.29 | USD 2,850 | |
| 2023-04-14 | 2023-04-13 | B Purchase |
General Counsel/Secretary Officer |
10,000
+10.3%
0.29USD 2,900 |
10,000 +10.3% | 0.29 | USD 2,900 | |
| 2023-04-14 | 2023-04-12 | B Purchase |
Chief Medical Officer Officer |
10,000
+7.2%
0.29USD 2,850 |
10,000 +7.2% | 0.29 | USD 2,850 | |
| 2023-04-14 | 2023-04-12 | B Purchase |
General Counsel/Secretary Officer |
15,000
+18.3%
0.29USD 4,350 |
15,000 +18.3% | 0.29 | USD 4,350 | |
| 2022-03-28 | 2022-03-28 | B Purchase |
Chief Financial Officer Officer |
2,500
+2.9%
1.40USD 3,500 |
2,500 +2.9% | 1.40 | USD 3,500 | |
| 2022-03-28 | 2022-03-25 | B Purchase |
Chief Financial Officer Officer |
2,136
+2.6%
1.49USD 3,182 |
2,136 +2.6% | 1.49 | USD 3,182 | |
| 2022-03-28 | 2022-03-25 | B Purchase |
Chief Financial Officer Officer |
5
+0.0%
1.48USD 7 |
5 +0.0% | 1.48 | USD 7 | |
| 2022-03-28 | 2022-03-25 | B Purchase |
Chief Financial Officer Officer |
356
+0.4%
1.45USD 516 |
356 +0.4% | 1.45 | USD 516 | |
| 2022-03-28 | 2022-03-24 | B Purchase |
Chief Financial Officer Officer |
3
+0.0%
1.45USD 4 |
3 +0.0% | 1.45 | USD 4 | |
| 2022-01-31 | 2022-01-28 | B Purchase |
Chief Financial Officer Officer |
2,500
+3.1%
1.65USD 4,125 |
2,500 +3.1% | 1.65 | USD 4,125 | |
| 2022-01-31 | 2022-01-28 | B Purchase |
General Counsel/Secretary Officer |
5,000
+12.5%
1.63USD 8,150 |
5,000 +12.5% | 1.63 | USD 8,150 | |
| 2022-01-31 | 2022-01-27 | B Purchase |
Chief Financial Officer Officer |
5,000
+6.6%
1.70USD 8,500 |
5,000 +6.6% | 1.70 | USD 8,500 | |
| 2022-01-31 | 2022-01-27 | B Purchase |
Chief Financial Officer Officer |
5,000
+7.1%
1.80USD 9,000 |
5,000 +7.1% | 1.80 | USD 9,000 | |
| 2022-01-31 | 2022-01-27 | B Purchase |
Chief Executive Officer Executive Director |
25,000
+116.0%
1.68USD 42,080 |
25,000 +116.0% | 1.68 | USD 42,080 | |
| 2022-01-31 | 2022-01-27 | B Purchase |
General Counsel/Secretary Officer |
8,500
+27.1%
1.78USD 15,130 |
8,500 +27.1% | 1.78 | USD 15,130 | |
| 2022-01-31 | 2022-01-27 | B Purchase |
Chief Medical Officer Officer |
10,000
+17.5%
1.69USD 16,900 |
10,000 +17.5% | 1.69 | USD 16,900 | |
| 2021-06-15 | 2021-06-11 | B Purchase |
General Counsel/Secretary Officer |
1,500
+inf%
5.45USD 8,175 |
1,500 +inf% | 5.45 | USD 8,175 | |
| 2020-09-02 | 2020-09-01 | B Purchase | Non-Executive Director |
71,429
+13789.4%
2.10USD 150,001 |
71,429 +13789.4% | 2.10 | USD 150,001 | |
| 2020-07-23 | 2020-07-21 | B Purchase |
Shanghai Pharmaceutical (USA) Inc. Large shareholder |
1,049,317
+42.1%
2.38USD 2,499,998 |
1,049,317 +42.1% | 2.38 | USD 2,499,998 | |
| 2020-07-23 | 2020-07-21 | B Purchase | Non-Executive Director |
10,000
+inf%
2.38USD 23,825 |
10,000 +inf% | 2.38 | USD 23,825 | |
| 2020-07-23 | 2020-07-21 | B Purchase |
Legal Counsel Officer |
41,972
+836.9%
2.38USD 99,998 |
41,972 +836.9% | 2.38 | USD 99,998 | |
| 2020-05-22 | 2020-05-21 | B Purchase | Non-Executive Director |
17,412
0.00USD 0 |
17,412 | 0.00 | USD 0 | |
| 2018-06-26 | 2018-06-26 | B Purchase |
Wills Robert James Executive Chairman Executive Director |
5,000
+3.8%
16.75USD 83,750 |
5,000 +3.8% | 16.75 | USD 83,750 | |
| 2018-06-22 | 2018-06-20 | S Sale |
DOGGRELL HENRY PATTON VP, Chief Legal Officer |
7,351
-14.4%
19.01USD 139,708 |
7,351 -14.4% | 19.01 | USD 139,708 | |
| 2018-06-22 | 2018-06-20 | S Sale |
Shackelford Jason T Prin Fin. & Acct. Officer |
9,279
-32.3%
19.01USD 176,350 |
9,279 -32.3% | 19.01 | USD 176,350 | |
| 2018-01-09 | 2018-01-05 | S Sale |
Shackelford Jason T Prin Fin. & Acct. Officer Officer |
2,379
-7.6%
11.13USD 26,478 |
2,379 -7.6% | 11.13 | USD 26,478 | |
| 2018-01-09 | 2018-01-05 | S Sale |
Prin Fin. & Acct. Officer Officer |
711
-2.2%
12.02USD 8,546 |
711 -2.2% | 12.02 | USD 8,546 | |
| 2018-01-09 | 2018-01-05 | S Sale |
DOGGRELL HENRY PATTON VP, Chief Legal Officer Officer |
3,823
-7.0%
11.13USD 42,550 |
3,823 -7.0% | 11.13 | USD 42,550 | |
| 2018-01-09 | 2018-01-05 | S Sale |
DOGGRELL HENRY PATTON VP, Chief Legal Officer Officer |
1,142
-2.0%
12.02USD 13,727 |
1,142 -2.0% | 12.02 | USD 13,727 | |
| 2018-01-09 | 2018-01-05 | S Sale |
HANOVER MARC STEVEN Chief Executive Officer Executive Director |
5,628
-4.3%
11.13USD 62,640 |
5,628 -4.3% | 11.13 | USD 62,640 | |
| 2018-01-09 | 2018-01-05 | S Sale |
HANOVER MARC STEVEN Chief Executive Officer Executive Director |
1,681
-1.3%
12.02USD 20,206 |
1,681 -1.3% | 12.02 | USD 20,206 | |
| 2017-10-02 | 2017-09-29 | B Purchase |
Pyramid Peak Foundation Large shareholder |
565,291
0.00USD 0 |
565,291 | 0.00 | USD 0 | |
| 2017-02-28 | 2016-10-28 | S Sale |
Young Diane C. VP, Chief Medical Officer |
500
-100.0%
7.70USD 3,850 |
500 -100.0% | 7.70 | USD 3,850 | |
| 2016-10-17 | 2016-10-14 | B Purchase |
Pyramid Peak Foundation Large shareholder |
7,716,049
+25.3%
0.81USD 6,250,000 |
7,716,049 +25.3% | 0.81 | USD 6,250,000 | |
| 2016-06-20 | 2016-06-16 | B Purchase |
Wills Robert James Executive Chairman Executive Director |
100,000
+9.1%
0.65USD 65,360 |
100,000 +9.1% | 0.65 | USD 65,360 | |
| 2016-03-02 | 2016-03-01 | B Purchase |
GLASS J KENNETH Non-Executive Director |
44,000
+31.5%
0.60USD 26,400 |
44,000 +31.5% | 0.60 | USD 26,400 | |
| 2016-01-26 | 2016-01-26 | B Purchase |
HANOVER MARC STEVEN Chief Executive Officer Executive Director |
4,000
+0.3%
0.65USD 2,600 |
4,000 +0.3% | 0.65 | USD 2,600 | |
| 2016-01-25 | 2016-01-25 | B Purchase |
HANOVER MARC STEVEN Chief Executive Officer Executive Director |
12,813
+1.0%
0.63USD 8,067 |
12,813 +1.0% | 0.63 | USD 8,067 | |
| 2016-01-19 | 2016-01-19 | B Purchase |
HANOVER MARC STEVEN Chief Executive Officer Executive Director |
25,000
+2.1%
0.50USD 12,428 |
25,000 +2.1% | 0.50 | USD 12,428 | |
| 2016-01-15 | 2016-01-15 | B Purchase |
HANOVER MARC STEVEN Chief Executive Officer Executive Director |
22,100
+1.9%
0.49USD 10,889 |
22,100 +1.9% | 0.49 | USD 10,889 | |
| 2016-01-15 | 2016-01-14 | B Purchase |
HANOVER MARC STEVEN Chief Executive Officer Executive Director |
2,900
+0.2%
0.47USD 1,377 |
2,900 +0.2% | 0.47 | USD 1,377 | |
| 2015-12-28 | 2015-12-24 | B Purchase |
GLASS J KENNETH Non-Executive Director |
100
+0.1%
0.79USD 79 |
100 +0.1% | 0.79 | USD 79 | |
| 2015-12-23 | 2015-12-23 | B Purchase |
GLASS J KENNETH Non-Executive Director |
600
+0.4%
0.79USD 474 |
600 +0.4% | 0.79 | USD 474 | |
| 2015-12-23 | 2015-12-22 | B Purchase |
GLASS J KENNETH Non-Executive Director |
1,307
+0.9%
0.78USD 1,019 |
1,307 +0.9% | 0.78 | USD 1,019 | |
| 2015-12-21 | 2015-12-21 | B Purchase |
GLASS J KENNETH Non-Executive Director |
39,900
+40.8%
0.78USD 31,122 |
39,900 +40.8% | 0.78 | USD 31,122 | |
| 2015-05-20 | 2015-05-19 | B Purchase |
GLASS J KENNETH Non-Executive Director |
24,500
+inf%
1.25USD 30,625 |
24,500 +inf% | 1.25 | USD 30,625 | |
| 2015-05-14 | 2015-05-14 | B Purchase |
Wills Robert James Executive Chairman Executive Director |
36,440
+57.3%
0.98USD 35,711 |
36,440 +57.3% | 0.98 | USD 35,711 | |
| 2015-05-14 | 2015-05-13 | B Purchase |
Wills Robert James Executive Chairman Executive Director |
9,700
+18.0%
0.88USD 8,536 |
9,700 +18.0% | 0.88 | USD 8,536 | |
| 2015-05-13 | 2015-05-11 | B Purchase |
Wills Robert James Executive Chairman Executive Director |
3,860
+7.7%
0.80USD 3,088 |
3,860 +7.7% | 0.80 | USD 3,088 | |
| 2015-05-11 | 2015-05-08 | B Purchase |
DOGGRELL HENRY PATTON VP, Chief Legal Officer Officer |
25,477
+inf%
0.80USD 20,382 |
25,477 +inf% | 0.80 | USD 20,382 | |
| 2015-05-11 | 2015-05-08 | B Purchase |
Wills Robert James Executive Chairman Executive Director |
50,000
+inf%
0.80USD 40,000 |
50,000 +inf% | 0.80 | USD 40,000 | |
| 2015-04-23 | 2015-04-22 | B Purchase |
GLASS J KENNETH Non-Executive Director |
10,000
+11.4%
0.72USD 7,200 |
10,000 +11.4% | 0.72 | USD 7,200 | |
| 2015-04-22 | 2015-04-21 | B Purchase |
GLASS J KENNETH Non-Executive Director |
7,656
+9.5%
0.71USD 5,436 |
7,656 +9.5% | 0.71 | USD 5,436 | |
| 2015-04-22 | 2015-04-20 | B Purchase |
GLASS J KENNETH Non-Executive Director |
3,952
+5.2%
0.72USD 2,845 |
3,952 +5.2% | 0.72 | USD 2,845 | |
| 2015-04-15 | 2015-04-15 | B Purchase |
GLASS J KENNETH Non-Executive Director |
3,300
+4.5%
0.72USD 2,376 |
3,300 +4.5% | 0.72 | USD 2,376 | |
| 2015-04-13 | 2015-04-10 | B Purchase |
GLASS J KENNETH Non-Executive Director |
16,400
+29.0%
0.67USD 10,988 |
16,400 +29.0% | 0.67 | USD 10,988 | |
| 2014-09-23 | 2014-09-23 | B Purchase |
HANOVER MARC STEVEN Interim CEO, President and COO Executive Director |
5,000
+2.4%
0.75USD 3,750 |
5,000 +2.4% | 0.75 | USD 3,750 | |
| 2014-09-17 | 2014-09-17 | B Purchase |
HANOVER MARC STEVEN Interim CEO, President and COO Executive Director |
10,000
+5.0%
0.74USD 7,432 |
10,000 +5.0% | 0.74 | USD 7,432 | |
| 2014-08-21 | 2014-08-21 | B Purchase |
HANOVER MARC STEVEN Interim CEO, President and COO Executive Director |
10,000
+5.3%
1.00USD 10,000 |
10,000 +5.3% | 1.00 | USD 10,000 | |
| 2014-08-21 | 2014-08-20 | B Purchase |
HANOVER MARC STEVEN Interim CEO, President and COO Executive Director |
10,000
+5.6%
1.00USD 10,000 |
10,000 +5.6% | 1.00 | USD 10,000 | |
| 2014-08-19 | 2014-08-19 | B Purchase |
HANOVER MARC STEVEN Interim CEO, President and COO Executive Director |
8,348
+4.9%
1.01USD 8,448 |
8,348 +4.9% | 1.01 | USD 8,448 | |
| 2014-08-19 | 2014-08-15 | B Purchase |
HANOVER MARC STEVEN Interim CEO, President and COO Executive Director |
1,652
+1.0%
1.00USD 1,652 |
1,652 +1.0% | 1.00 | USD 1,652 | |
| 2014-08-08 | 2014-08-08 | B Purchase |
HANOVER MARC STEVEN Interim CEO, President and COO Executive Director |
10,000
+6.3%
0.95USD 9,532 |
10,000 +6.3% | 0.95 | USD 9,532 |